S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in
OTCMKTS:NSPX

Inspyr Therapeutics News Headlines

$0.02
0.00 (0.00 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.02
Now: $0.02
$0.02
50-Day Range
$0.01
MA: $0.01
$0.04
52-Week Range
$0.00
Now: $0.02
$1.13
Volume4.69 million shs
Average Volume28.79 million shs
Market Capitalization$2.85 million
P/E RatioN/A
Dividend YieldN/A
Beta-16.55

Headlines

Inspyr Therapeutics (OTCMKTS NSPX) News Headlines Today

Source:
SourceHeadline
Inspyr Therapeutics, Inc.: Inspyr Therapeutics Further Strengthens Global Intellectual PropertyInspyr Therapeutics, Inc.: Inspyr Therapeutics Further Strengthens Global Intellectual Property
finanznachrichten.de - February 18 at 2:45 PM
Inspyr Therapeutics Further Strengthens Global Intellectual PropertyInspyr Therapeutics Further Strengthens Global Intellectual Property
finance.yahoo.com - February 18 at 2:45 PM
Short Interest in Inspyr Therapeutics, Inc. (OTCMKTS:NSPX) Grows By 161.0%Short Interest in Inspyr Therapeutics, Inc. (OTCMKTS:NSPX) Grows By 161.0%
americanbankingnews.com - February 12 at 2:42 PM
Inspyr Therapeutics, Inc.: Inspyr Therapeutics Secures $500,000 to Support the Development of its Adenosine PipelineInspyr Therapeutics, Inc.: Inspyr Therapeutics Secures $500,000 to Support the Development of its Adenosine Pipeline
finanznachrichten.de - January 12 at 10:54 AM
Inspyr Therapeutics Secures $500,000 to Support the Development of its Adenosine PipelineInspyr Therapeutics Secures $500,000 to Support the Development of its Adenosine Pipeline
finance.yahoo.com - January 12 at 10:54 AM
Inspyr Therapeutics, Inc.: Inspyr Therapeutics Strengthens Global Intellectual PropertyInspyr Therapeutics, Inc.: Inspyr Therapeutics Strengthens Global Intellectual Property
finanznachrichten.de - December 11 at 11:44 PM
Inspyr Therapeutics Strengthens Global Intellectual PropertyInspyr Therapeutics Strengthens Global Intellectual Property
finance.yahoo.com - December 10 at 12:39 PM
Inspyr Therapeutics, Inc.: Inspyr Therapeutics Reports 2020 Third Quarter Results and Business UpdateInspyr Therapeutics, Inc.: Inspyr Therapeutics Reports 2020 Third Quarter Results and Business Update
finanznachrichten.de - November 25 at 7:11 PM
Inspyr Therapeutics Reports 2020 Third Quarter Results and Business UpdateInspyr Therapeutics Reports 2020 Third Quarter Results and Business Update
finance.yahoo.com - November 24 at 7:35 AM
Inspyr Therapeutics, Inc.: Inspyr Therapeutics Acquires a Novel Immuno-Onoclogy Precision Targeting Platform for the Treatment of CancerInspyr Therapeutics, Inc.: Inspyr Therapeutics Acquires a Novel Immuno-Onoclogy Precision Targeting Platform for the Treatment of Cancer
finanznachrichten.de - October 10 at 9:30 AM
Inspyr reacquires a novel immuno-onoclogy precision from RidgewayInspyr reacquires a novel immuno-onoclogy precision from Ridgeway
seekingalpha.com - October 8 at 5:57 PM
Inspyr Therapeutics Inc.Inspyr Therapeutics Inc.
www.barrons.com - May 26 at 10:25 PM
This page was last updated on 2/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.